Top brand choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
100mg/300mg/300mg
|
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) is a three-in-one medication. It's indication is for treating HIV-1 infection in adults and pediatric patients who weigh at least 77 pounds (35 kilograms) and:
Fact Table | |
Formula |
C17H11ClF3N5O3 |
License |
US DailyMed |
Bioavailability |
64%, 86%, 25% |
Legal status |
Rx-Only |
Chemical Name |
Doravirine, lamivudine, and tenofovir disoproxil fumarate |
Elimination half-life |
15 hrs |
Dosage (Strength) |
100mg/300mg/300mg |
Pregnancy |
Consult Doctor |
Brands |
Delstrigo |
Protein binding |
Around 75% |
PubChem CID |
- |
MedlinePlus |
a618049 |
ChEBI |
- |
ATC code |
J05AR24 |
DrugBank |
- |
KEGG |
D11396 |
Routes of administration |
By mouth |
Delstrigo is a tablet (100 mg doravirine/300 mg lamivudine/300 mg tenofovir disoproxil fumarate).
The typical dose is one tablet by mouth one time a day. Delstrigo can be taken with or without food.
Your dose may be adjusted with the use of rifabutin.
Doravine (a non-nucleoside reverse transcriptase inhibitor), lamivudine (a nucleoside analogue reverse transcriptase inhibitor), and tenofovir disoproxil fumarate (a nucleoside analogue reverse transcriptase inhibitor) are the active ingredients in Delstrigo.
You should not take Delstrigo if you are allergic to doravine, lamivudine, tenofovir disoproxil fumarate, or any of Delstrigo's ingredients.
You should not take Delstrigo if you are taking:
WARNING: POSTTREATMENT ACUTE EXACERBATION OF HEPATITIS B See full prescribing information for complete boxed warning. Severe acute exacerbations of hepatitis B (HBV) have been reported in patients coinfected with HIV-1 and HBV who have discontinued lamivudine or tenofovir disoproxil fumarate (TDF), two of the components of DELSTRIGO. Closely monitor hepatic function in these patients. If appropriate, initiation of anti-hepatitis B therapy may be warranted. |
Delstrigo can cause side effects, including dizziness, unusual dreams, and nausea.
Contact your doctor right away if you develop side effects that are bothersome or persistent.